Severity, therapeutic, and activity tear biomarkers in dry eye disease: An analysis from a phase III clinical trial

To evaluate the effect of 0.1%-fluorometholone (FML) on tear inflammatory molecule levels after 22-days treatment in dry eye disease (DED) patients exposed to an adverse controlled environment (ACE), identifying different biomarkers. Analysis of a double-masked randomized clinical trial. Forty-one D...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The ocular surface 2018-07, Vol.16 (3), p.368-376
Hauptverfasser:	Pinto-Fraga, José, Enríquez-de-Salamanca, Amalia, Calonge, Margarita, González-García, María J., López-Miguel, Alberto, López-de la Rosa, Alberto, García-Vázquez, Carmen, Calder, Virginia, Stern, Michael E., Fernández, Itziar
Format:	Artikel
Sprache:	eng
Schlagworte:	Clinical trial endpoint Cytokine Dry eye disease Environmental conditions Tear biomarkers
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!